Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2026-01-07 @ 2:23 AM
Study NCT ID:
NCT01509560
Status:
COMPLETED
Last Update Posted:
2017-02-23
First Post:
2012-01-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican ® in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Transplantation Blood
Sponsor:
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Ev02 (Everolimus-GvHD)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None